Latest for Progressive Familial Intrahepatic Cholestasis
See all trialsThe week in rare diseaseEach date is the day a change was posted. Open an item to see where things stand now.
More about Progressive Familial Intrahepatic Cholestasis
These molecular defects impair bile formation and secretion, leading to intrahepatic cholestasis with progressive hepatocellular injury, inflammation, and fibrosis. Patients develop severe cholestasis with jaundice, intense pruritus that severely impacts quality of life, hepatosplenomegaly, failure to thrive, and growth retardation.
Keep reading about Progressive Familial Intrahepatic Cholestasis
Without intervention, most progress to cirrhosis and liver failure requiring transplantation by late childhood or adolescence. According to MedlinePlus Genetics, PFIC2 (BSEP deficiency) carries a higher risk of hepatocellular carcinoma, a liver cancer, and PFIC3 (MDR3 deficiency) a higher risk of cholangiocarcinoma, a bile duct cancer. Laboratory studies reveal elevated aminotransferases, hyperbilirubinemia, and a characteristic pattern of normal or minimally elevated gamma-glutamyl transferase (GGT) in PFIC1 and PFIC2, while GGT is high in PFIC3, which helps distinguish PFIC from other cholestatic disorders.
What are the symptoms of Progressive Familial Intrahepatic Cholestasis?
These are common symptoms of Progressive Familial Intrahepatic Cholestasis, and how strong they are varies from person to person.
- Jaundice and cholestasis in infancy or childhood
- Severe pruritus (itching)
- Hepatosplenomegaly
- Failure to thrive
- Progressive liver fibrosis and cirrhosis
- Portal hypertension in advanced stages
Who gets Progressive Familial Intrahepatic Cholestasis?
Progressive familial intrahepatic cholestasis typically manifests before age 10 years, with earlier onset and more severe phenotypes in PFIC2. The condition affects males and females equally. Since it follows autosomal recessive inheritance, both parents must carry mutations for disease manifestation. Parents are typically asymptomatic carriers.
Prevalence varies by ethnicity and geographic region, PFIC1 was first described as Byler disease in an Amish family, and an ATP8B1 variant is known among the Amish.
Next steps: find trials you might fitsee approved treatmentsget help payingget alerts
Which medicines are FDA-approved for Progressive Familial Intrahepatic Cholestasis?
There are currently 2 FDA-approved medications for Progressive Familial Intrahepatic Cholestasis.
Source: openFDA drug labeling data. This list may not include all treatments. Always consult your doctor.
How to get help paying for Progressive Familial Intrahepatic Cholestasis treatment
Charity funds and drugmaker programs for Progressive Familial Intrahepatic Cholestasis, checked at the source.
- From a charity · PFIC NetworkPFIC Financial Assistance Program fundOpen
Pays for: Uncovered medical expenses (genetic testing, vitamins, travel), insurance premiums and copays, rent or utilities, up to $1,000 per year.
The foundation says: “The PFIC Network accepts applications throughout the year on a rolling basis.”
Every program and fund for Progressive Familial Intrahepatic Cholestasis, by insurance →
Side effects people have reported to the FDA
Side effects people have reported to the FDA
Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.
Loading side effect data...
Diagnosis and genetic testing
Genetic testing for Progressive Familial Intrahepatic Cholestasis
Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.
Finding labs...
Trusted Progressive Familial Intrahepatic Cholestasis resources
Reputable organizations and medical references for learning more about Progressive Familial Intrahepatic Cholestasis, including disease registries, foundation resources, and clinical guidelines.
- PFIC Network
- MedlinePlus Genetics - Progressive familial intrahepatic cholestasis
- Knisely AS. Progressive familial intrahepatic cholestasis: a personal perspective. Pediatric and Developmental Pathology, 2000
- Srivastava A. Progressive familial intrahepatic cholestasis. Journal of Clinical and Experimental Hepatology, 2014
- NORD - Low Gamma-GT Familial Intrahepatic Cholestasis
- NIH GARD - PFIC